valine has been researched along with Cardiometabolic Syndrome in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auriola, S; Giacco, R; Hanhineva, K; Jokkala, J; Kärkkäinen, O; Koistinen, V; Kolehmainen, M; Lankinen, MA; Lehtonen, M; Leppänen, J; Micard, V; Mykkänen, H; Poutanen, K; Riccardi, G; Rivellese, AAA; Rosa-Sibakov, N; Schwab, U; Uusitupa, M; Vitale, M | 1 |
| El-Bassossy, HM; El-Fawal, R; Fahmy, A; Watson, ML | 1 |
| Bales, CW; Bethel, MA; Califf, RM; Davies, MJ; Haffner, SM; Holman, RR; Huffman, KM; Kraus, WE; McMurray, JJ; Sun, JL; Thomas, L; Tuomilehto, J; Yates, T | 1 |
| Anraku, Y; Inami, S; Inoue, T; Kato, T; Kikegawa, Y; Nakamoto, A; Node, K; Suzuki, A; Toyoda, S; Tsukada, K | 1 |
| Elenkova, A; Kirilov, G; Lozanov, V; Mitev, V; Orbetzova, M; Shigarminova, R; Zacharieva, S | 1 |
| Deedwania, PC; Fonseca, VA; Haffner, SM; Hsueh, WA; Keeling, L; Sica, DA; Sowers, JR; Zappe, DH | 1 |
| Carter, JD; Cole, BK; Keller, SR; Nadler, JL; Nunemaker, CS; Wu, R | 1 |
| Derosa, G; Ferrari, I; Fogari, R; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Konta, T; Kubota, I; Miyamoto, T; Miyashita, T; Nishiyama, S; Nitobe, J; Shishido, T; Takasaki, S; Takeishi, Y; Watanabe, T | 1 |
| Imig, JD; Khan, AH | 1 |
| Brown, L; Sernia, C | 1 |
| Jin, D; Miyazaki, M; Takai, S | 1 |
| Abe, S; Furusho, Y; Hamasaki, S; Ikeda, Y; Kajiya, S; Kihara, K; Lee, S; Minagoe, S; Miyata, M; Nakamura, S; Ohba, I; Sasaki, T; Tateishi, S; Tei, C; Torii, H | 1 |
| Durik, M; Roks, AJ; Sevá Pessôa, B | 1 |
| Horiguchi, CS; Makino, H; Miyoshi, T; Murakami, K; Nakamura, Y; Ogawa, D; Sasaki, M; Uchida, HA; Wada, J | 1 |
| Brozinick, JT; Grove, K; Hawkins, E; Hoang Bui, H; Kievit, P; Kuo, MS; Tan, B | 1 |
| Björntorp, P; Bouchard, C; Rosmond, R | 1 |
| Atzmon, G; Barzilai, N; Cheng, S; Cupples, AL; Lipton, R; Schaefer, EJ; Schechter, C; Shuldiner, AR | 1 |
| Cucuianu, M; Dican, L | 1 |
| Hausberg, M; Hohage, H; Kosch, M | 1 |
| Acikel, C; Caglar, K; Celik, T; Eyileten, T; Oguz, Y; Sonmez, A; Vural, A; Yavuz, I; Yenicesu, M; Yilmaz, MI | 1 |
| Ichikawa, Y | 1 |
2 review(s) available for valine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
The renin-angiotensin system, bone marrow and progenitor cells.
Topics: Adipogenesis; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow; Erythropoiesis; Hematopoiesis; Humans; Kidney; Mesenchymal Stem Cells; Metabolic Syndrome; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stem Cells; Tetrazoles; Valine; Valsartan | 2012 |
Coagulation factor XIII and atherothrombosis. A mini-review.
Topics: Arteriosclerosis; Diabetes Mellitus, Type 2; Factor XIII; Fibrinolysis; Humans; Insulin Resistance; Leucine; Metabolic Syndrome; Polymorphism, Genetic; Valine | 2003 |
9 trial(s) available for valine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Diets rich in whole grains increase betainized compounds associated with glucose metabolism.
Topics: Adult; Aged; Animals; Betaine; Blood Glucose; Chromatography, Liquid; Cohort Studies; Diet; Dietary Fiber; Feeding Behavior; Female; Finland; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Italy; Male; Metabolic Syndrome; Mice, Inbred C57BL; Middle Aged; Pipecolic Acids; Postprandial Period; Secale; Tandem Mass Spectrometry; Triticum; Valine; Whole Grains | 2018 |
Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake.
Topics: Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Metabolic Syndrome; Middle Aged; Potassium; Prospective Studies; Sodium; Sodium Chloride, Dietary; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2015 |
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prediabetic State; Risk Factors; Tetrazoles; Valine; Valsartan; Young Adult | 2008 |
Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2010 |
Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets).
Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; C-Reactive Protein; Diabetes Complications; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Tetrazoles; Valine; Valsartan | 2011 |
Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome.
Topics: Adipocytes; Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Apolipoproteins E; Biomarkers; Cardiovascular Diseases; Disease Models, Animal; Female; Fibrinolysis; Humans; Hypertension; Japan; Male; Metabolic Syndrome; Mice; Mice, Knockout; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2012 |
The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Female; Humans; Hypertension; Insulin Resistance; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Subcutaneous Fat; Telmisartan; Tetrazoles; Tomography, X-Ray Computed; Treatment Outcome; Valine; Valsartan; Waist Circumference | 2013 |
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
Topics: Adiponectin; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Doxazosin; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Metoprolol; Middle Aged; Predictive Value of Tests; Prospective Studies; Ramipril; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2007 |
Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
11 other study(ies) available for valine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Arginase inhibition alleviates hypertension in the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arginase; Blood Pressure; Citrulline; Endothelium, Vascular; Enzyme Inhibitors; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide; Ornithine; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Valine | 2013 |
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.
Topics: Aged; Cyclohexanes; Diet; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Nateglinide; Phenylalanine; Placebos; Tetrazoles; Valine; Valsartan | 2014 |
Homocysteine, renin and aldosterone in patients with Cushing's syndrome.
Topics: Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Chromatography, High Pressure Liquid; Cushing Syndrome; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Male; Metabolic Syndrome; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2008 |
Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Body Weight; Cytokines; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Gene Expression; Glucose Intolerance; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mitochondria; Tetrazoles; Valine; Valsartan | 2010 |
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Dietary Fats; Disease Models, Animal; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity.
Topics: Animals; Benzimidazoles; Benzoates; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor γ.
Topics: Adiponectin; Adipose Tissue; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Gene Expression Regulation; Glucose Transporter Type 4; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Irbesartan; Male; Metabolic Syndrome; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; RNA, Messenger; Tetrazoles; Thiazolidinediones; Valine; Valsartan | 2011 |
Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet.
Topics: Animals; Biomarkers; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Disease Progression; Fructose; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Risk Factors; Serine C-Palmitoyltransferase; Sphingolipids; Valine | 2013 |
Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome.
Topics: Alanine; Alleles; Blood Glucose; Blood Pressure; Humans; Insulin; Ion Channels; Male; Membrane Transport Proteins; Metabolic Syndrome; Middle Aged; Mitochondrial Proteins; Obesity; Phenotype; Proteins; Sweden; Uncoupling Protein 2; Valine | 2002 |
Unique lipoprotein phenotype and genotype associated with exceptional longevity.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Carrier Proteins; Case-Control Studies; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Codon; Female; Genotype; Glycoproteins; Humans; Hypertension; Isoleucine; Jews; Lipoproteins; Longevity; Male; Metabolic Syndrome; Particle Size; Phenotype; Polymorphism, Genetic; Valine | 2003 |
[Hypertension and diabetic nephropathy, a dangerous duo].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Male; Metabolic Syndrome; Ramipril; Tetrazoles; Valine; Valsartan | 2005 |